Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

GenSight Biologics S.A. GSGTF

Set alert

Price alert · GSGTF

All alert types
0.08 USD 0.00 0.00%

At close · Oct 29

0.45 Day range 0.45
0.08 52-week range 0.1901
YTD
-57.92%
1 year
-57.92%
Open
0.48
Prev close
0.08
Mkt cap
19.62M
Vol
756
Avg vol
6
EPS
-0.09
P/E
0.00
More statistics
Low
0.45
High
0.45

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for GSGTF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-10.64 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -2.0×
FY 2016: -5.0×FY 2017: -5.4×FY 2018: -1.2×FY 2019: -2.4×FY 2020: -7.2×FY 2021: -9.4×FY 2022: -4.9×FY 2023: -0.8×FY 2024: -1.4×FY 2025: -2.0×
FY 2016 5y median -2.0× FY 2025
P/S 24003×
FY 2016: 36.7×FY 2017: 35.2×FY 2018: 9.4×FY 2019: 107×FY 2020: 56.2×FY 2021: 50.8×FY 2022: 52.8×FY 2023: 16.2×FY 2024: 12.8×FY 2025: 24003×
FY 2016 5y median 50.8× FY 2025
P/B -1.0×
FY 2016: 2.1×FY 2017: 2.4×FY 2018: 1.7×FY 2019: 6.4×FY 2020: 21.0×FY 2021: 16.8×FY 2022: -8.9×FY 2023: -0.7×FY 2024: -0.7×FY 2025: -1.0×
FY 2016 5y median -0.7× FY 2025
P/FCF -2.6×
FY 2016: -5.5×FY 2017: -6.9×FY 2018: -1.4×FY 2019: -2.6×FY 2020: -16.4×FY 2021: -15.6×FY 2022: -4.0×FY 2023: -0.8×FY 2024: -1.5×FY 2025: -2.6×
FY 2016 5y median -2.6× FY 2025
EV/EBITDA -3.1×
FY 2016: -2.7×FY 2017: -3.3×FY 2018: -0.5×FY 2019: -2.1×FY 2020: -9.3×FY 2021: -8.7×FY 2022: -5.4×FY 2023: -2.0×FY 2024: -3.2×FY 2025: -3.1×
FY 2016 5y median -3.2× FY 2025
EV/Sales 34451×
FY 2016: 19.7×FY 2017: 21.0×FY 2018: 4.1×FY 2019: 89.3×FY 2020: 50.8×FY 2021: 44.8×FY 2022: 55.6×FY 2023: 33.1×FY 2024: 23.9×FY 2025: 34451×
FY 2016 5y median 44.8× FY 2025
FCF Yield -38.2%
FY 2016: -18.0%FY 2017: -14.6%FY 2018: -71.7%FY 2019: -37.8%FY 2020: -6.1%FY 2021: -6.4%FY 2022: -24.9%FY 2023: -120.1%FY 2024: -67.5%FY 2025: -38.2%
FY 2016 5y median -38.2% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 93.2%FY 2017: 93.9%FY 2018: 92.8%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -1170494.6%
FY 2016: -733.7%FY 2017: -648.0%FY 2018: -760.4%FY 2019: -4328.3%FY 2020: -567.5%FY 2021: -533.1%FY 2022: -1078.0%FY 2023: -2343.8%FY 2024: -1054.2%FY 2025: -1170494.6%
FY 2016 5y median -1078.0% FY 2025
Net Margin -1203594.4%
FY 2016: -735.8%FY 2017: -651.3%FY 2018: -769.7%FY 2019: -4387.1%FY 2020: -774.1%FY 2021: -542.4%FY 2022: -1069.9%FY 2023: -2069.5%FY 2024: -933.4%FY 2025: -1203594.4%
FY 2016 5y median -1069.9% FY 2025
ROE 48.3%
FY 2016: -41.4%FY 2017: -43.8%FY 2018: -140.1%FY 2019: -261.5%FY 2020: -289.5%FY 2021: -179.0%FY 2022: 180.8%FY 2023: 85.5%FY 2024: 52.0%FY 2025: 48.3%
FY 2016 5y median 52.0% FY 2025
ROIC 1520.8%
FY 2016: -39.1%FY 2017: -41.3%FY 2018: -120.7%FY 2019: -131.5%FY 2020: -75.1%FY 2021: -70.6%FY 2022: -202.8%FY 2023: -2282.5%FY 2024: -776.3%FY 2025: 1520.8%
FY 2016 5y median -202.8% FY 2025
ROA -145.8%
FY 2016: -37.3%FY 2017: -38.8%FY 2018: -90.5%FY 2019: -94.5%FY 2020: -71.8%FY 2021: -50.5%FY 2022: -106.5%FY 2023: -287.1%FY 2024: -130.2%FY 2025: -145.8%
FY 2016 5y median -130.2% FY 2025

Growth (YoY)

Revenue -99.9%
FY 2016: -15.7%FY 2017: 23.4%FY 2018: 17.4%FY 2019: -83.9%FY 2020: 527.7%FY 2021: 20.1%FY 2022: -51.1%FY 2023: -50.9%FY 2024: 18.4%FY 2025: -99.9%
FY 2016 FY 2025
Operating Income 26.0%
FY 2016: -61.2%FY 2017: -9.0%FY 2018: -37.7%FY 2019: 8.3%FY 2020: 17.7%FY 2021: -12.8%FY 2022: 1.0%FY 2023: -6.7%FY 2024: 46.8%FY 2025: 26.0%
FY 2016 FY 2025
EPS (diluted) 52.2%
FY 2016: -12.4%FY 2017: 19.1%FY 2018: -24.5%FY 2019: 21.2%FY 2020: 10.2%FY 2021: 35.1%FY 2022: 4.8%FY 2023: 10.0%FY 2024: 68.5%FY 2025: 52.2%
FY 2016 FY 2025
Free Cash Flow 29.1%
FY 2016: -54.9%FY 2017: 4.1%FY 2018: -53.4%FY 2019: 3.4%FY 2020: 46.6%FY 2021: -14.1%FY 2022: -98.0%FY 2023: 27.4%FY 2024: 47.6%FY 2025: 29.1%
FY 2016 FY 2025

Financial Health

Current Ratio 0.4×
FY 2016: 20.1×FY 2017: 14.9×FY 2018: 3.7×FY 2019: 2.6×FY 2020: 2.6×FY 2021: 2.4×FY 2022: 1.6×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.4×
FY 2016 5y median 0.4× FY 2025
Quick Ratio 0.4×
FY 2016: 21.2×FY 2017: 14.9×FY 2018: 2.7×FY 2019: 2.6×FY 2020: 2.6×FY 2021: 2.2×FY 2022: 1.0×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.4×
FY 2016 5y median 0.4× FY 2025
Debt / Equity -0.5×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.6×FY 2020: 1.2×FY 2021: 0.8×FY 2022: -1.2×FY 2023: -0.8×FY 2024: -0.7×FY 2025: -0.5×
FY 2016 5y median -0.7× FY 2025
Net Debt / EBITDA -0.9×
FY 2016: 2.3×FY 2017: 2.2×FY 2018: 0.7×FY 2019: 0.4×FY 2020: 1.0×FY 2021: 1.2×FY 2022: -0.3×FY 2023: -1.0×FY 2024: -1.5×FY 2025: -0.9×
FY 2016 5y median -0.9× FY 2025
Interest Coverage -11.9×
FY 2016: -246×FY 2017: -316×FY 2018: -81.0×FY 2019: -74.4×FY 2020: -14.5×FY 2021: -13.0×FY 2022: -10.5×FY 2023: -9.4×FY 2024: -10.2×FY 2025: -11.9×
FY 2016 5y median -10.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31